Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-blind, Vehicle Controlled, Parallel-group Comparison Trial to Demonstrate the Superiority of 0.3% and 1% OPA-15406 Ointment to the Vehicle in Pediatric Patients With Atopic Dermatitis (Phase 3 Trial)
Brief Summary: To demonstrate the superiority of the investigational medicinal product (IMP; 0.3% OPA-15406 ointment, 1% OPA-15406 ointment, or vehicle) to the vehicle when administered twice daily for 4 weeks using success rate in Investigator's Global Assessment (IGA) at Week 4 as the primary endpoint in pediatric patients with Atopic Dermatitis (AD).


Options:
A: Arm Label: GW870086X; Type: OTHER; Interventions: Drug: GW870086X | Intervention Type: DRUG; Name: GW870086X; Assigned to Arm(s): GW870086X
B: Arm Label: Roflumilast Cream 0.05%; Type: ACTIVE_COMPARATOR; Interventions: Drug: Roflumilast Cream 0.05% | Arm Label: Roflumilast Cream 0.15%; Type: ACTIVE_COMPARATOR; Interventions: Drug: Roflumilast Cream 0.15% | Arm Label: Vehicle Cream; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle Cream | Intervention Type: DRUG; Name: Roflumilast Cream 0.05%; Assigned to Arm(s): Roflumilast Cream 0.05% | Intervention Type: DRUG; Name: Roflumilast Cream 0.15%; Assigned to Arm(s): Roflumilast Cream 0.15% | Intervention Type: DRUG; Name: Vehicle Cream; Assigned to Arm(s): Vehicle Cream
C: Arm Label: Vehicle Control (VC) Period: Vehicle Cream BID; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle cream | Arm Label: VC Period: Ruxolitinib 0.75% Cream BID; Type: EXPERIMENTAL; Interventions: Drug: Ruxolitinib cream | Arm Label: VC Period: Ruxolitinib 1.5% Cream BID; Type: EXPERIMENTAL; Interventions: Drug: Ruxolitinib cream | Arm Label: Long-Term Safety (LTS) Period: Vehicle Cream to Ruxolitinib 0.75% Cream BID; Type: EXPERIMENTAL; Interventions: Drug: Ruxolitinib cream | Arm Label: LTS Period: Vehicle Cream to Ruxolitinib 1.5% Cream BID; Type: EXPERIMENTAL; Interventions: Drug: Ruxolitinib cream | Arm Label: LTS Period: Ruxolitinib 0.75% Cream BID; Type: EXPERIMENTAL; Interventions: Drug: Ruxolitinib cream | Arm Label: LTS Period: Ruxolitinib 1.5% Cream BID; Type: EXPERIMENTAL; Interventions: Drug: Ruxolitinib cream | Intervention Type: DRUG; Name: Ruxolitinib cream; Assigned to Arm(s): LTS Period: Ruxolitinib 0.75% Cream BID, LTS Period: Ruxolitinib 1.5% Cream BID, LTS Period: Vehicle Cream to Ruxolitinib 1.5% Cream BID, Long-Term Safety (LTS) Period: Vehicle Cream to Ruxolitinib 0.75% Cream BID, VC Period: Ruxolitinib 0.75% Cream BID, VC Period: Ruxolitinib 1.5% Cream BID | Intervention Type: DRUG; Name: Vehicle cream; Assigned to Arm(s): Vehicle Control (VC) Period: Vehicle Cream BID
D: Arm Label: 0.3% OPA-15406; Type: EXPERIMENTAL; Interventions: Drug: 0.3% OPA-15406 | Arm Label: 1% OPA-15406; Type: EXPERIMENTAL; Interventions: Drug: 1% OPA-15406 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebos | Intervention Type: DRUG; Name: 0.3% OPA-15406; Assigned to Arm(s): 0.3% OPA-15406 | Intervention Type: DRUG; Name: 1% OPA-15406; Assigned to Arm(s): 1% OPA-15406 | Intervention Type: DRUG; Name: Placebos; Assigned to Arm(s): Placebo

Answer: D